# Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH

> **NCT05546060** · PHASE1 · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Hemophagocytic Lymphohistiocytosis

## Interventions

- **DRUG:** Venetoclax
- **DRUG:** Dexamethasone
- **DRUG:** Etoposide

## Key facts

- **NCT ID:** NCT05546060
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05546060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05546060, "Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05546060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*